acadia-pharm.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php | ||
Meta Tags
| Title | Acadia |
| Description | Trailblazing Breakthroughs So More You Shines As a leader in developing and commercializing innovative therapies for central nervous system disorders we are committed to improving the lives of |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.55.23.95 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
acadia-pharm.com Valuation
|
US$6,735,396
Last updated: 2022-06-15 02:53:55
acadia-pharm.com has Semrush global rank of 1,571,445. acadia-pharm.com has an estimated worth of US$ 6,735,396, based on its estimated Ads revenue. acadia-pharm.com receives approximately 777,161 unique visitors each day. Its web server is located in United States, with IP address 52.55.23.95. According to SiteAdvisor, acadia-pharm.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,735,396 |
| Daily Ads Revenue | US$6,218 |
| Monthly Ads Revenue | US$186,519 |
| Yearly Ads Revenue | US$2,238,224 |
| Daily Unique Visitors | 51,811 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| acadia-pharm.com. | A | 300 | IP: 52.55.23.95 |
| acadia-pharm.com. | NS | 300 | NS Record: ns-1607.awsdns-08.co.uk. |
| acadia-pharm.com. | NS | 300 | NS Record: ns-341.awsdns-42.com. |
| acadia-pharm.com. | NS | 300 | NS Record: ns-624.awsdns-14.net. |
| acadia-pharm.com. | NS | 300 | NS Record: ns-1197.awsdns-21.org. |
| acadia-pharm.com. | MX | 300 | MX Record: 5 us-smtp-inbound-1.mimecast.com. |
| acadia-pharm.com. | MX | 300 | MX Record: 5 us-smtp-inbound-2.mimecast.com. |
| acadia-pharm.com. | TXT | 300 | TXT Record: ip4:13.111.112.246 ip4:13.111.112.247 ip4:13.111.112.248 ip4:52.191.169.195/28 ip4:208.185.229.0/24 ip4:208.185.235.0/24 ip4:148.59.108.0/23 ip4:148.59.106.0/23 include:spf.m.appature.com include:_netblocks.mimecast.com include:_spf.salesforce.com ~all |
| acadia-pharm.com. | TXT | 300 | TXT Record: ip4:13.111.19.67 ip4:13.111.19.68 ip4:13.111.19.69 ip4:13.111.19.70 ip4:13.111.19.71 ip4:13.111.19.72 ip4:13.111.19.73 ip4:13.111.19.74 ip4:13.111.19.75 ip4:13.111.19.76 ip4:13.111.19.77 ip4:13.111.19.78 ip4:13.111.19.82 ip4:13.111.19.83 ip4:13.111.19.212 ip4:13.111.19.213 ip4:13.111.19.214 ip4:13.111.19.215 |
| acadia-pharm.com. | TXT | 300 | TXT Record: kBq93H2xgHWTkC6uRogN |
| acadia-pharm.com. | TXT | 300 | TXT Record: smartsheet-site-validation=lyGGlfqaubMqXgfcLEzLBy--JjdRI0DX |
| acadia-pharm.com. | TXT | 300 | TXT Record: v=DMARC1; p=none; fo=1; rua=mailto:dmarc_rua@emaildefense.proofpoint.com; ruf=mailto:dmarc_ruf@emaildefense.proofpoint.com |
| acadia-pharm.com. | TXT | 300 | TXT Record: v=spf1 mx ip4:74.84.203.40 ip4:38.105.5.48/28 ip4:38.105.5.65/26 ip4:104.129.65.1/26 ip4:66.18.116.249/32 ip4:96.46.150.152 ip4:173.254.189.74 ip4:5.61.117.80/28 ip4:5.61.117.96/28 ip4:5.61.117.112/28 ip4:130.117.41.147/32 ip4:130.117.41.148/32 ip4:216.146.32.161 ip4:216.146.32.188 ip4:216.146.32.187 ip4:216.146.32.186 ip4:216.146.32.185 ip4:81.93.173.201 ip4:81.93.164.103 ip4:43.228.187.74 ip4:13.111.19.65 ip4:13.111.19.66 |
| acadia-pharm.com. | TXT | 300 | TXT Record: ZOOM_verify_km1JKyMTSBSF2BnQ0zgB1Q |
| acadia-pharm.com. | TXT | 300 | TXT Record: apple-domain-verification=fVRmxVdtGCfmtJcX |
| acadia-pharm.com. | TXT | 300 | TXT Record: cisco-ci-domain-verification=1ae90102b0a62880329d51875b69cfe7313d569386c0a8d062cea6b138e385bb |
HtmlToTextCheckTime:2022-06-15 02:53:55
| Home Contact Home About Management Team Board Of Directors Our Purpose, Mission & Values History Product Pipeline Dementia-Related Psychosis Rett Syndrome Schizophrenia – Negative Symptoms Early Stage Clinical Programs Resources Parkinson’s Disease Psychosis Clinical Trials Investigator Initiated Studies Medical Education Grants Scientific Publications Compliance Partnering Investors Stock Information News Releases Events & Presentations Sec Filings Corporate Governance Financial Information Analyst Coverage Annual Report and Proxy Information Request Email Alerts Media Careers Current Openings Contact About Management Team Board Of Directors Our Purpose, Mission & Values History Product Pipeline Dementia-Related Psychosis Rett Syndrome Schizophrenia – Negative Symptoms Early Stage Clinical Programs Resources Parkinson’s Disease Psychosis Clinical Trials Investigator Initiated Studies Medical Education Grants Scientific Publications Compliance Partnering Investors Stock Information |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Thu, 21 Oct 2021 06:46:57 GMT Server: Apache Feature-Policy: camera 'none'; microphone 'none' Location: https://acadia-pharm.com/ Cache-Control: max-age=0 Expires: Thu, 21 Oct 2021 06:46:57 GMT Content-Type: text/html; charset=iso-8859-1 HTTP/2 301 date: Thu, 21 Oct 2021 06:46:57 GMT server: Apache x-pingback: https://www.acadia-pharm.com/xmlrpc.php x-redirect-by: WordPress feature-policy: camera 'none'; microphone 'none' location: https://www.acadia-pharm.com/ cache-control: max-age=0, public expires: Thu, 21 Oct 2021 06:46:57 GMT vary: User-Agent expect-ct: enforce, max-age=43200, report-uri="https://www.acadia-pharm.com/contact/" strict-transport-security: max-age=31536000; includeSubDomains; preload content-security-policy: upgrade-insecure-requests x-frame-options: SAMEORIGIN x-content-type-options: nosniff x-xss-protection: 1; mode=block x-ua-compatible: IE=edge content-type: text/html; charset=UTF-8 HTTP/2 200 date: Thu, 21 Oct 2021 06:46:57 GMT server: Apache feature-policy: camera 'none'; microphone 'none' cache-control: max-age=0, public expires: Thu, 21 Oct 2021 06:46:57 GMT vary: Accept-Encoding,User-Agent expect-ct: enforce, max-age=43200, report-uri="https://www.acadia-pharm.com/contact/" strict-transport-security: max-age=31536000; includeSubDomains; preload content-security-policy: upgrade-insecure-requests x-frame-options: SAMEORIGIN x-content-type-options: nosniff x-xss-protection: 1; mode=block x-ua-compatible: IE=edge content-type: text/html; charset=UTF-8 |
acadia-pharm.com Whois Information
Domain Name: ACADIA-PHARM.COM Registry Domain ID: 2880968_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-08-16T18:28:02Z Creation Date: 1997-08-14T04:00:00Z Registry Expiry Date: 2023-08-13T04:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1197.AWSDNS-21.ORG Name Server: NS-1607.AWSDNS-08.CO.UK Name Server: NS-341.AWSDNS-42.COM Name Server: NS-624.AWSDNS-14.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T23:34:37Z <<< |